Key risks
- Revenue growth has stalled after recovering to ₹18.54 Cr in Mar 2021; verify whether plateau reflects demand weakness or capacity constraints.
- Valuation at PE 29.58 is elevated relative to revenue growth profile, leaving limited margin for earnings misses.
- Institutional investor interest is minimal (FII 0.26%, DII 0.6%), suggesting limited analyst coverage or research interest.
- Stock declined 32.44% over one year despite operating margin recovery, signalling investor concern about earnings quality or sustainability.
Generated analysis · source review pending